SMPD1 and neoplasm: An alternative approach to radiosensitization might be via asmase gene therapy, employing an adenoviral vector such as Ad5H2E-mVEGFR2-ASMase that utilizes a preproendothelin promoter activated exclusively in dividing tumor neoangiogenic endothelium to overexpress ASMase therein to provide a therapeutic ratio (24).